WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: COVID-19 | Health | Hydroxychloroquine | International Medicine & Public Health | Malaria | WHO